$59.38
-3.86[-6.10%]
At close: Apr 25
$59.38
0[0.00%]
After Hours: 5:58PM EDT
Exact Sciences
(NASDAQ:EXAS)Exact Sciences Stock (NASDAQ:EXAS), Guidance and Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Date Announced | ticker | Company Name | Period | Period Year | Min EPS | Max EPS | Estimate | Min Rev | Max Rev | Revenue Estimate | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/21/2024 | EXAS | Exact Sciences | FY | 2024 | — | — | — | $2.81B | $2.85B | $2.83B | Get Alert |
| 01/07/2024 | EXAS | Exact Sciences | FY | 2023 | — | — | — | $2.50B | $2.50B | $2.48B | Get Alert |
| 01/07/2024 | EXAS | Exact Sciences | FY | 2024 | — | — | — | $2.83B | $2.83B | $2.83B | Get Alert |
| 01/07/2024 | EXAS | Exact Sciences | Q4 | 2023 | — | — | — | $645.50M | $647.50M | $631.52M | Get Alert |
| 11/01/2023 | EXAS | Exact Sciences | FY | 2023 | — | — | — | $2.48B | $2.49B | $2.46B | Get Alert |
| 08/01/2023 | EXAS | Exact Sciences | FY | 2023 | — | — | — | $2.44B | $2.47B | $2.42B | Get Alert |
| 06/21/2023 | EXAS | Exact Sciences | FY | 2023 | — | — | — | $2.40B | $2.40B | $2.42B | Get Alert |
| 05/09/2023 | EXAS | Exact Sciences | FY | 2023 | — | — | — | $2.38B | $2.42B | $2.30B | Get Alert |
| 02/21/2023 | EXAS | Exact Sciences | FY | 2023 | — | — | — | $2.27B | $2.31B | $2.29B | Get Alert |
| 01/08/2023 | EXAS | Exact Sciences | FY | 2022 | — | — | — | $2.08B | $2.08B | $2.03B | Get Alert |
| 01/08/2023 | EXAS | Exact Sciences | Q4 | 2022 | — | — | — | $550.70M | $552.70M | $506.48M | Get Alert |
| 11/03/2022 | EXAS | Exact Sciences | FY | 2022 | — | — | — | $2.02B | $2.04B | $2.01B | Get Alert |
| 08/02/2022 | EXAS | Exact Sciences | FY | 2022 | — | — | — | $1.98B | $2.02B | $2.02B | Get Alert |
| 04/26/2022 | EXAS | Exact Sciences | FY | 2022 | — | — | — | $1.99B | $2.03B | $2.01B | Get Alert |
| 02/22/2022 | EXAS | Exact Sciences | FY | 2022 | — | — | — | $1.98B | $2.03B | $1.99B | Get Alert |
| 01/09/2022 | EXAS | Exact Sciences | Q4 | 2021 | — | — | — | $472.00M | $475.00M | $440.30M | Get Alert |
| 01/09/2022 | EXAS | Exact Sciences | FY | 2021 | — | — | — | $1.76B | $1.77B | $1.73B | Get Alert |
| 11/02/2021 | EXAS | Exact Sciences | FY | 2021 | — | — | — | $1.72B | $1.74B | $1.73B | Get Alert |
| 07/28/2021 | EXAS | Exact Sciences | FY | 2021 | — | — | — | $1.71B | $1.75B | $1.72B | Get Alert |
FAQ
What is the most recent guidance for Exact Sciences (EXAS)?
There have been no specific sales or earnings guidance reported for Exact Sciences in recent months.
Browse guidance and forecast on all stocks.